₹16.09 for Q4 which increased by 68.63% Y-o-Y. Ajanta Pharmaceuticals has delivered 4.7% return in the last 1 week, 22.16% return in the last 6 months, and 7.22% YTD return.
Currently, Ajanta Pharmaceuticals has a market cap of ₹28129.56 Cr and 52wk high/low of ₹2353.95 & ₹1235.89 respectively. As of 04 May, 2024, out of 10 analysts covering the company, 1 analyst has given a Strong Sell rating, 1 analyst has given a Sell rating, 1 analyst has given a Hold rating, 2 analysts have given a Buy rating, and 5 analysts have given a Strong Buy rating.
Read more on livemint.com